{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:34:12Z","timestamp":1757622852943,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China","award":["2021ZQNZD010"],"award-info":[{"award-number":["2021ZQNZD010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03316-2","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:53:31Z","timestamp":1754906011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Qin","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenquan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sufang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"3","key":"3316_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3316_CR2","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3316_CR3","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/hed.24531","volume":"38","author":"SC Jayaram","year":"2016","unstructured":"Jayaram SC, Muzaffar SJ, Ahmed I, Dhanda J, Paleri V, Mehanna H. Efficacy, outcomes, and complication rates of different surgical and nonsurgical treatment modalities for recurrent\/residual oropharyngeal carcinoma: a systematic review and meta-analysis. Head Neck. 2016;38(12):1855\u201361.","journal-title":"Head Neck"},{"issue":"11","key":"3316_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","volume":"14","author":"M Nishino","year":"2017","unstructured":"Nishino M, Ramaiya NH, Hatabu H, Hodi FS. Monitoring immune-checkpoint blockade: response evaluation and biomarker development. Nat Rev Clin Oncol. 2017;14(11):655\u201368.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7536","key":"3316_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"CGA Network","year":"2015","unstructured":"Network CGA. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576\u201382.","journal-title":"Nature"},{"key":"3316_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fgene.2016.00026","volume":"7","author":"MJ Milligan","year":"2016","unstructured":"Milligan MJ, Harvey E, Yu A, Morgan AL, Smith DL, Zhang E, et al. Global intersection of long non-coding RNAs with processed and unprocessed pseudogenes in the human genome. Front Genet. 2016;7:26.","journal-title":"Front Genet"},{"issue":"7","key":"3316_CR7","doi-asserted-by":"publisher","first-page":"10080","DOI":"10.1002\/jcp.27941","volume":"234","author":"R Abdollahzadeh","year":"2019","unstructured":"Abdollahzadeh R, Daraei A, Mansoori Y, Sepahvand M, Amoli MM, Tavakkoly-Bazzaz J. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: a new look at hallmarks of breast cancer. J Cell Physiol. 2019;234(7):10080\u2013100.","journal-title":"J Cell Physiol"},{"issue":"12","key":"3316_CR8","first-page":"2886","volume":"35","author":"C Glenfield","year":"2018","unstructured":"Glenfield C, McLysaght A. Pseudogenes provide evolutionary evidence for the competitive endogenous RNA hypothesis. Mol Biol Evol. 2018;35(12):2886\u201399.","journal-title":"Mol Biol Evol"},{"issue":"5","key":"3316_CR9","doi-asserted-by":"publisher","first-page":"046","DOI":"10.1093\/gigascience\/giz046","volume":"8","author":"TS Johnson","year":"2019","unstructured":"Johnson TS, Li S, Franz E, Huang Z, Dan Li S, Campbell MJ, et al. PseudoFuN: deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers. Gigascience. 2019;8(5):046.","journal-title":"Gigascience"},{"issue":"1","key":"3316_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/jmedgenet-2014-102785","volume":"52","author":"L Xiao-Jie","year":"2015","unstructured":"Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X. Pseudogene in cancer: real functions and promising signature. J Med Genet. 2015;52(1):17\u201324.","journal-title":"J Med Genet"},{"issue":"6","key":"3316_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/genes10060414","volume":"10","author":"F Liu","year":"2019","unstructured":"Liu F, Xing L, Zhang X, Zhang X. A four-pseudogene classifier identified by machine learning serves as a novel prognostic marker for survival of osteosarcoma. Genes. 2019;10(6):414.","journal-title":"Genes"},{"issue":"1","key":"3316_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41590-017-0005-y","volume":"19","author":"JJ Chiang","year":"2018","unstructured":"Chiang JJ, Sparrer KMJ, van Gent M, L\u00e4ssig C, Huang T, Osterrieder N, et al. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol. 2018;19(1):53\u201362.","journal-title":"Nat Immunol"},{"issue":"6","key":"3316_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nmeth.2445","volume":"10","author":"M Hein\u00e4niemi","year":"2013","unstructured":"Hein\u00e4niemi M, Nykter M, Kramer R, Wienecke-Baldacchino A, Sinkkonen L, Zhou JX, et al. Gene-pair expression signatures reveal lineage control. Nat Methods. 2013;10(6):577\u201383.","journal-title":"Nat Methods"},{"issue":"11","key":"3316_CR14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaoncol.2017.1609","volume":"3","author":"B Li","year":"2017","unstructured":"Li B, Cui Y, Diehn M, Li R. Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung cancer. JAMA Oncol. 2017;3(11):1529\u201337.","journal-title":"JAMA Oncol"},{"key":"3316_CR15","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"3316_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1\u20132):48\u201361.","journal-title":"Cell"},{"issue":"1","key":"3316_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1\u201310.","journal-title":"Immunity"},{"issue":"10","key":"3316_CR18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med. 2018;24(10):1545\u20139.","journal-title":"Nat Med"},{"issue":"10","key":"3316_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"3316_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"9","key":"3316_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"29","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;29(9):559.","journal-title":"BMC Bioinform"},{"issue":"7","key":"3316_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","volume":"26","author":"G Yu","year":"2010","unstructured":"Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010;26(7):976\u20138.","journal-title":"Bioinformatics"},{"key":"3316_CR23","doi-asserted-by":"publisher","first-page":"217076","DOI":"10.1016\/j.canlet.2024.217076","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhao Y, Song H, Li Y, Liu Z, Ye Z, et al. Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications. Cancer Lett. 2024;19:217076.","journal-title":"Cancer Lett"},{"key":"3316_CR24","doi-asserted-by":"publisher","first-page":"818977","DOI":"10.3389\/fonc.2022.818977","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Du T, Chen X. ANXA2P2: a potential immunological and prognostic signature in ovarian serous cystadenocarcinoma via pan-carcinoma synthesis. Front Oncol. 2022;12:818977.","journal-title":"Front Oncol"},{"issue":"1","key":"3316_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12957-021-02231-4","volume":"19","author":"Y Ding","year":"2021","unstructured":"Ding Y, Liu N, Chen M, Xu Y, Fang S, Xiang W, et al. Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA. World J Surg Oncol. 2021;19(1):133.","journal-title":"World J Surg Oncol"},{"issue":"17","key":"3316_CR26","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.7150\/thno.76689","volume":"12","author":"L Tan","year":"2022","unstructured":"Tan L, Qin Y, Xie R, Xia T, Duan X, Peng L, et al. N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma. Theranostics. 2022;12(17):7267\u201388.","journal-title":"Theranostics"},{"issue":"200","key":"3316_CR27","doi-asserted-by":"publisher","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","volume":"5","author":"S Spranger","year":"2013","unstructured":"Spranger S, Spaapen RM, Zha Y, Williams J, Meng Y, Ha TT, et al. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci Transl Med. 2013;5(200):200ra116.","journal-title":"Sci Transl Med"},{"issue":"8","key":"3316_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/intimm\/dxw014","volume":"28","author":"S Spranger","year":"2016","unstructured":"Spranger S. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment. Int Immunol. 2016;28(8):383\u201391.","journal-title":"Int Immunol"},{"issue":"4","key":"3316_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1053\/j.seminoncol.2015.05.011","volume":"42","author":"TF Gajewski","year":"2015","unstructured":"Gajewski TF. The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment. Semin Oncol. 2015;42(4):663\u201371.","journal-title":"Semin Oncol"},{"key":"3316_CR30","doi-asserted-by":"publisher","first-page":"653711","DOI":"10.3389\/fimmu.2021.653711","volume":"12","author":"R Zhao","year":"2021","unstructured":"Zhao R, Li B, Zhang S, He Z, Pan Z, Guo Q, et al. The N6-methyladenosine-modified pseudogene HSPA7 correlates with the tumor microenvironment and predicts the response to immune checkpoint therapy in glioblastoma. Front Immunol. 2021;12:653711.","journal-title":"Front Immunol"},{"issue":"44","key":"3316_CR31","doi-asserted-by":"publisher","first-page":"26422","DOI":"10.1074\/jbc.R115.665869","volume":"290","author":"L Balagopalan","year":"2015","unstructured":"Balagopalan L, Kortum RL, Coussens NP, Barr VA, Samelson LE. The linker for activation of T cells (LAT) signaling hub: from signaling complexes to microclusters. J Biol Chem. 2015;290(44):26422\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"3316_CR32","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41467-018-04419-x","volume":"9","author":"L Balagopalan","year":"2018","unstructured":"Balagopalan L, Yi J, Nguyen T, McIntire KM, Harned AS, Narayan K, et al. Plasma membrane LAT activation precedes vesicular recruitment defining two phases of early T-cell activation. Nat Commun. 2018;9(1):2013.","journal-title":"Nat Commun"},{"issue":"4","key":"3316_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/eji.201948233","volume":"50","author":"TT Luu","year":"2020","unstructured":"Luu TT, Wagner AK, Schmied L, Meinke S, Freund JE, Kambayashi T, et al. IL-15 and CD155 expression regulate LAT expression in murine DNAM1+ NK cells, enhancing their effectors functions. Eur J Immunol. 2020;50(4):494\u2013504.","journal-title":"Eur J Immunol"},{"key":"3316_CR34","doi-asserted-by":"publisher","first-page":"673196","DOI":"10.3389\/fimmu.2021.673196","volume":"12","author":"WL Lo","year":"2021","unstructured":"Lo WL, Weiss A. Adapting T cell receptor ligand discrimination capability via LAT. Front Immunol. 2021;12:673196.","journal-title":"Front Immunol"},{"issue":"121","key":"3316_CR35","doi-asserted-by":"publisher","first-page":"pe16","DOI":"10.1126\/scisignal.3121pe16","volume":"3","author":"DD Billadeau","year":"2010","unstructured":"Billadeau DD. T cell activation at the immunological synapse: vesicles emerge for LATer signaling. Sci Signal. 2010;3(121):pe16.","journal-title":"Sci Signal"},{"issue":"1","key":"3316_CR36","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1038\/s41598-021-86048-x","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu Y, Xu F, Lv Y, Wang S, Li J, Zhou C, et al. A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients. Sci Rep. 2021;11(1):6374.","journal-title":"Sci Rep"},{"issue":"1","key":"3316_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12885-022-09673-3","volume":"22","author":"Z Cai","year":"2022","unstructured":"Cai Z, Tang B, Chen L, Lei W. Mast cell marker gene signature in head and neck squamous cell carcinoma. BMC Cancer. 2022;22(1):577.","journal-title":"BMC Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03316-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03316-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03316-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:40:46Z","timestamp":1757374846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03316-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3316"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03316-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Ethics Committee of Fujian Cancer Hospital (Fuzhou, China; approval number K2022-074-01). Prior to their participation in any study-related research, each patient provided written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent obtained directly from patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1528"}}